Suvro Sankha Datta: Reporting Auto-Anti-Jk Antibodies in Children with Hematological Disorders
Suvro Sankha Datta, Senior Consultant and Head Transfusion Medicine at Tata Medical Center, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Auto-anti-Jk antibodies are extremely rare in nature and can pose significant diagnostic uncertainty.
In this series, we report the presence of auto-anti-Jk in three pediatric cases with hematological disorders.
Blood group genotyping seems to be a useful way to distinguish auto- versus allo-anti-Jk antibodies.
Long-term follow-up data was used to determine the clinical behaviour of auto-Jk antibodies.”
Title: Distinguishing patients with suspected auto- versus allo-anti-Jka antibodies and highlighting the clinical significance: A case series from India
Authors: Najla Haneefa Basheela, Rashmi K. Pandey, Aniruddha Hazra, Durba Biswas, Debapriya Basu, Suvro Sankha Datta
Read the Full Article on Transfusion and Apheresis Science.
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 24, 2026, 14:29Brian O Mahony: Switching, Bleeding, Surgery, And Washout For Emicizumab And Rebalancing Agents
-
Apr 24, 2026, 14:10Abel Sandmann։ How Common Are Cerebral Cavernous Malformations, Actually?
-
Apr 24, 2026, 13:43Mahesan Subramaniam: Raspberry Support Heart, Brain, and Metabolic Health
-
Apr 24, 2026, 13:34Joakim Nordanstig: SWEDEPAD Data Show Early Risk Of Limb Loss With Paclitaxel-Coated Devices
-
Apr 24, 2026, 13:18Lukas Jeker։ Making Genomic Medicine Affordable for More Patients
-
Apr 24, 2026, 11:27Caterina Casari: Thank You WFH for a Great Congress
-
Apr 24, 2026, 11:15Megan Adediran: A Moment to Pause, Learn, and Be Renewed
-
Apr 24, 2026, 11:09Veronica Sanchez: AHA Warns Most Women and Girls May Face Cardiovascular Disease by 2050
-
Apr 24, 2026, 09:38Luis Ferreira Moita: Rethinking Sepsis Care Through the Lancet Commission Initiative